IL1β Cancer Research Results

IL1β, interleukin-1 beta: Click to Expand ⟱
Source:
Type:
The term "IL-1" is often used as an umbrella term for the interleukin-1 family, which includes multiple cytokines. The two best-known members are IL-1α and IL-1β.
IL-1β is secreted from cells and plays a major systemic role in inflammation. It is a crucial mediator in the inflammatory response and is involved in the fever response, activation of endothelial cells, and leukocyte recruitment.
Its increased expression is commonly linked to:
  – Promotion of a pro-inflammatory microenvironment that supports tumor growth.
  – Enhanced angiogenesis, invasion, and metastasis.
  – Recruitment of myeloid cells that may further suppress antitumor immunity.

High expression of either tends to be associated with a more aggressive phenotype and worse prognosis in many cancer types.


BC, Breast Cancer: Click to Expand ⟱
Breast Cancer

Scientific Papers found: Click to Expand⟱
297- ALA,    Insights on the Use of α-Lipoic Acid for Therapeutic Purposes
- Review, BC, SkBr3 - Review, neuroblastoma, SK-N-SH - Review, AD, NA
PDH↑, TumCG↓, ROS↑, AMPK↑, EGR4↓, Half-Life↓, BioAv↝, *GSH↑, *IronCh↑, *ROS↓, *antiOx↑, *neuroP↑, *Ach↑, *lipid-P↓, *IL1β↓, *IL6↓, TumCP↓, FDG↓, Apoptosis↑, AMPK↑, mTOR↓, EGFR↓, TumCI↓, TumCMig↓, *memory↑, *BioAv↑, *BioAv↝, *other↓, *other↝, *Half-Life↓, *BioAv↑, *ChAT↑, *GlucoseCon↑,
1779- MEL,    Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review
- Review, BC, NA
QoL↑, OS↑, Dose∅, antiOx↑, ROS↑, SOD↑, Catalase↑, GPx↑, Risk↓, NK cell↑, IL1β↓, IL6↓, TNF-α↓, radioP↑, chemoP↑, TumVol↓, TumMeta↓, angioG↓, ChemoSen↑, eff↑,
1231- PBG,    Caffeic acid phenethyl ester inhibits MDA-MB-231 cell proliferation in inflammatory microenvironment by suppressing glycolysis and lipid metabolism
- in-vitro, BC, MDA-MB-231
TumCP↓, TumCMig↓, TumCI↓, MMP↓, TLR4↓, TNF-α↓, NF-kB↓, IL1β↓, IL6↓, IRAK4↓, GLUT1↓, GLUT3↓, HK2↓, PFK↓, PKM2↓, LDHA↓, ACC↓, FASN↓, eff↓,
2381- PBG,    Chinese Poplar Propolis Inhibits MDA-MB-231 Cell Proliferation in an Inflammatory Microenvironment by Targeting Enzymes of the Glycolytic Pathway
- in-vitro, BC, MDA-MB-231
TumCP↓, TumCMig↓, TumCI↓, angioG↓, TNF-α↓, IL1β↓, IL6↓, NLRP3↓, Glycolysis↓, HK2↓, PFK↓, PKM2↓, LDHA↓, ROS↑, MMP↓,
3092- RES,    Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action
- Review, BC, MDA-MB-231 - Review, BC, MCF-7
TumCP↓, tumCV↓, TumCI↓, TumMeta↓, *antiOx↑, *cardioP↑, *Inflam↓, *neuroP↑, *Keap1↓, *NRF2↑, *ROS↓, p62↓, IL1β↓, CRP↓, VEGF↓, Bcl-2↓, MMP2↓, MMP9↓, FOXO4↓, POLD1↓, CK2↓, MMP↓, ROS↑, Apoptosis↑, TumCCA↑, Beclin-1↓, Ki-67↓, ATP↓, GlutMet↓, PFK↓, TGF-β↓, SMAD2↓, SMAD3↓, Vim?, Snail↓, Slug↓, E-cadherin↑, EMT↓, Zeb1↓, Fibronectin↓, IGF-1↓, PI3K↓, Akt↓, HO-1↑, eff↑, PD-1↓, CD8+↑, Th1 response↑, CSCs↓, RadioS↑, SIRT1↑, Hif1a↓, mTOR↓,
3419- TQ,    Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients
- in-vitro, BC, NA
*NLRP3↓, *IL1β↓, *Casp1?,

Showing Research Papers: 1 to 6 of 6

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 6

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress

antiOx↑, 1,   Catalase↑, 1,   GPx↑, 1,   HO-1↑, 1,   ROS↑, 4,   SOD↑, 1,  

Mitochondria & Bioenergetics

ATP↓, 1,   MMP↓, 3,  

Core Metabolism/Glycolysis

ACC↓, 1,   AMPK↑, 2,   FASN↓, 1,   FDG↓, 1,   GlutMet↓, 1,   Glycolysis↓, 1,   HK2↓, 2,   LDHA↓, 2,   PDH↑, 1,   PFK↓, 3,   PKM2↓, 2,   POLD1↓, 1,   SIRT1↑, 1,  

Cell Death

Akt↓, 1,   Apoptosis↑, 2,   Bcl-2↓, 1,   CK2↓, 1,  

Transcription & Epigenetics

tumCV↓, 1,  

Autophagy & Lysosomes

Beclin-1↓, 1,   p62↓, 1,  

Cell Cycle & Senescence

TumCCA↑, 1,  

Proliferation, Differentiation & Cell State

CSCs↓, 1,   EMT↓, 1,   FOXO4↓, 1,   IGF-1↓, 1,   mTOR↓, 2,   PI3K↓, 1,   TumCG↓, 1,  

Migration

E-cadherin↑, 1,   Fibronectin↓, 1,   Ki-67↓, 1,   MMP2↓, 1,   MMP9↓, 1,   Slug↓, 1,   SMAD2↓, 1,   SMAD3↓, 1,   Snail↓, 1,   TGF-β↓, 1,   TumCI↓, 4,   TumCMig↓, 3,   TumCP↓, 4,   TumMeta↓, 2,   Vim?, 1,   Zeb1↓, 1,  

Angiogenesis & Vasculature

angioG↓, 2,   EGFR↓, 1,   EGR4↓, 1,   Hif1a↓, 1,   VEGF↓, 1,  

Barriers & Transport

GLUT1↓, 1,   GLUT3↓, 1,  

Immune & Inflammatory Signaling

CRP↓, 1,   IL1β↓, 4,   IL6↓, 3,   IRAK4↓, 1,   NF-kB↓, 1,   NK cell↑, 1,   PD-1↓, 1,   Th1 response↑, 1,   TLR4↓, 1,   TNF-α↓, 3,  

Protein Aggregation

NLRP3↓, 1,  

Drug Metabolism & Resistance

BioAv↝, 1,   ChemoSen↑, 1,   Dose∅, 1,   eff↓, 1,   eff↑, 2,   Half-Life↓, 1,   RadioS↑, 1,  

Clinical Biomarkers

CRP↓, 1,   EGFR↓, 1,   IL6↓, 3,   Ki-67↓, 1,  

Functional Outcomes

chemoP↑, 1,   OS↑, 1,   QoL↑, 1,   radioP↑, 1,   Risk↓, 1,   TumVol↓, 1,  

Infection & Microbiome

CD8+↑, 1,  
Total Targets: 88

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress

antiOx↑, 2,   GSH↑, 1,   Keap1↓, 1,   lipid-P↓, 1,   NRF2↑, 1,   ROS↓, 2,  

Metal & Cofactor Biology

IronCh↑, 1,  

Core Metabolism/Glycolysis

GlucoseCon↑, 1,  

Cell Death

Casp1?, 1,  

Transcription & Epigenetics

Ach↑, 1,   other↓, 1,   other↝, 1,  

Immune & Inflammatory Signaling

IL1β↓, 2,   IL6↓, 1,   Inflam↓, 1,  

Synaptic & Neurotransmission

ChAT↑, 1,  

Protein Aggregation

NLRP3↓, 1,  

Drug Metabolism & Resistance

BioAv↑, 2,   BioAv↝, 1,   Half-Life↓, 1,  

Clinical Biomarkers

IL6↓, 1,  

Functional Outcomes

cardioP↑, 1,   memory↑, 1,   neuroP↑, 2,  
Total Targets: 24

Scientific Paper Hit Count for: IL1β, interleukin-1 beta
2 Propolis -bee glue
1 Alpha-Lipoic-Acid
1 Melatonin
1 Resveratrol
1 Thymoquinone
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:4  Cells:%  prod#:%  Target#:978  State#:%  Dir#:1
wNotes=0 sortOrder:rid,rpid

 

Home Page